U project backs hepatitis B vaccine, challenges Trump administration
Federal vaccine advisers in the Trump administration had proposed delaying the first doses, but a U review found no scientific basis for the switch.
More from Minnesota Business
Star Tribune Business
War made planting difficult. Now it could boost farmers' profits.
Minnesota Business
•
17h ago
Star Tribune Business
Ramstad: Fraud in Minnesota has not cost $9 billion, but it's hurt more
Minnesota Business
•
1d ago
Star Tribune Business
Summit Brewing could avoid foreclosure with new lender
Minnesota Business
•
3d ago
Star Tribune Business
Watch the replays of the North Star Summit sessions
Minnesota Business
•
3d ago